Zum Inhalt

HealthOSArzneimittel

Arbeitsbereiche

Nachschlagen

Wirkstoffe & Arzneimittelsicherheit

Exakte Wirkstoffkennungen und zitierbare Passagen zu Wechselwirkungen, Gegenanzeigen und Nebenwirkungen.

Ein Paarvergleich findet Originalpassagen, die den anderen Wirkstoff wörtlich nennen. Aussagen gelten für das jeweilige Präparat und seine Formulierung. Klassenbegriffe und abweichende Synonyme können fehlen. Kein Treffer bedeutet nicht, dass keine Wechselwirkung besteht.

RxNorm 05-Oct-2026 · geprüft 2026-10-25 · 1009 Präparate · 54812 Quellenpassagen · 148 strukturierte Aussagen. Automatisch aktualisiert, ohne menschliche Freigabe.

Quellenpassagen (1)

Nebenwirkungen · Drovelis

Drovelis 3 mg/14.2 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 15–16

HOS-146497 · Präparat HOS-099526

15 System organ Common Uncommon Rare class Renal and urinary Bladder spasm disorders Urine odour abnormal Pregnancy, Ectopic pregnancy puerperium and perinatal conditions Reproductive Breast pain Abnormal withdrawal Ovarian cyst system and breast Metrorrhagia bleeding(9) Lactation disorders disorders Vaginal haemorrhage Breast swelling Endometrial disorder Dysmenorrhoea Vulvovaginal disorder(10) Dysfunctional uterine Menorrhagia Vaginal discharge bleeding Premenstrual syndrome Pelvic pain Breast mass(11) Nipple disorder Uterine spasm Breast discolouration Uterine haemorrhage Coital bleeding Menometrorrhagia Dyspareunia General disorders Fatigue Malaise(12) and Oedema Pain administration site Chest pain Hyperthermia conditions Feeling abnormal Investigations Weight fluctuation Hepatic enzyme increased Blood pressure increased Lipids abnormal Renal function test abnormal Blood potassium increased Blood glucose increased Haemoglobin decreased Serum ferritin decreased Blood in urine (1) including affect lability, anger, euphoric mood, irritability, altered mood and mood swings (2) including depressed mood, depressive symptom, tearfulness and depression (3) including agitation, anxiety, generalised anxiety disorder and panic attack (4 ) including emotional disorder, emotional distress and crying (5) including night sweats, hyperhidrosis and cold sweat (6) including dry skin, rash and skin swelling (7) including dermatitis and eczema (8) including chloasma and skin hyperpigmentation (9) including abnormal withdrawal bleeding, amenorrhoea, menstrual disorder, irregular menstruation, oligomenorrhoea and polymenorrhoe (10) including vaginal odour, vulvovaginal discomfort, vulvovaginal dryness, vulvovaginal pain, vulvovaginal pruritus and vulvovaginal burning sensation (11) including breast mass and fibrocystic breast disease (12) including malaise and decreased performance status

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.

Vollständigen Kontext in der EMA-Fachinformation lesen →
Quellennachweis

Version 2026-03-10T12:55:00Z · SHA-256 69e66a6243c1d9a3de0a88ac010cbabd1405527c8e76c9065b3d238f26ce840f · Passage b6351cea02478bbdd62657c23347a9711e185b2cad75c0fe4df39a2ac1220795 · Zeichen 4470–7866 im Abschnitt

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.